To include your compound in the COVID-19 Resource Center, submit it here.

Atu027: Phase Ib/IIa ongoing

Silence said a DSMB recommended continuation into the main portion of an open-label, German Phase Ib/IIa trial evaluating

Read the full 180 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE